Podcast

Looking Ahead to 2022 With the Editors of AJMC®

The editors of The American Journal of Managed Care® and The American Journal of Accountable Care® reflect on the past year and discuss the themes and topics they expect to see in 2022.

On this episode of Managed Care Cast, we’re talking with the co-editors-in-chief of The American Journal of Managed Care®, Mark Fendrick, MD, and Michael Chernew, PhD, and the editor-in-chief of The American Journal of Accountable Care®, Dennis Scanlon, PhD. They look back on the past year and discuss the themes and topics they expect to see in the pages of the journals and in the world of health care in 2022.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Marilyn Glassberg, MD
Dr Caroline Vovan
Dr Caroline Vovan
Dr Caroline Vovan
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Jeffrey Fitzgerald, JD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Related Content
Cancer diagnosis financial strain | Image Credit: Maggie-sort.chatgpt.com
July 21st 2025

Cancer Diagnoses Bring Major Financial Burden for Privately Insured Adults

Maggie L. Shaw
In this new study, investigators sought to measure and attribute out-of-pocket costs to cancer stage and by diagnosis.
Managed Care Cast
Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
CMS Adminstrator Mehmet Oz, MD, MBA, speaks with AtlantiCare CEO Michael Charlton, MHL, during a visit to Atlantic City.
July 19th 2025

As CMS Embarks on “Rural Transformation,” a New Jersey Health System Weighs In

Mary Caffrey
CMS Administrator Mehmet Oz, MD, MBA, visited AtlantiCare leaders in Atlantic City, New Jersey, to discuss the need for legislative and regulatory reform, as well as the $50 billion Rural Transformation Program.
Managed Care Cast
July 8th 2025

Managed Care Cast News Roundup: July 8, 2025

Giuliana Grossi
Medical societies challenge HHS Secretary Robert F. Kennedy Jr's COVID-19 vaccine rollbacks, and more news updates from the week.
The first gene therapies for sickle cell disease were FDA approved in 2023, but high upfront costs have been barriers to patient access to these life-changing treatments. | Image credit: RFBSIP - stock.adobe.com
July 18th 2025

CGT Access Model Aims to Expand Access to Sickle Cell Treatments

Rose McNulty
States participating in the Cell and Gene Therapy (CGT) Access Model will be testing outcomes-based payments for sickle cell disease treatments.
AJMC
July 18th 2025

Assertive Community Treatment for Complex and Costly Patients

Trygve Dolber, MD Patrick Runnels, MD, MBA Peter J. Pronovost, MD, PhD
Assertive community treatment, a strongly evidence-based practice for delivering care to individuals with schizophrenia and low health care engagement, is applicable to disengaged, medically complex patients.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo